Global Immunotherapy Drugs Market to Reach Valuation of USD 274.6 billion by 2025


 

The rising prevalence of target diseases, increased demand for monoclonal antibodies and biosimilars, increasing use of immunotherapy medications over traditional therapies and a favorable approval scenario are all contributing to the market's growth. However, in the product development cycle, the timeline challenges, side effects, manufacturing complexities, and a high attrition rate are common.

The global  immunotherapy drugs market is expected to grow at a CAGR of 11.0 percent to USD 274.6 billion by 2025, up from USD 163.0 billion in 2020.

Monoclonal antibodies, checkpoint inhibitors, interferons & interleukins, and other immunotherapies are the several types of immunotherapy medications available. In 2019, monoclonal antibodies accounted for the greatest portion of the worldwide immunotherapy medicines market. This huge percentage can be due to their high specificity and fewer adverse effects, as well as an increased focus on tailored therapies, industry activities, and the growing prevalence and the patient pool of target diseases.

This market is divided into cancer, autoimmune and inflammatory diseases, infectious illnesses, and other therapeutic areas based on therapeutic area. By therapeutic area, cancer accounted for the highest proportion of the worldwide immunotherapy medicines market in 2019. The growing prevalence of cancer increased research interest in this area, and reimbursement coverage for immunotherapies for oncology are all factors contributing to this segment's size.

The global immunotherapy drugs market is categorized into hospitals, clinics, and other end-users based on end users. In 2019, hospitals held the highest proportion of the global market. Over the projected period, this segment is expected to increase at the fastest rate of 12.1 percent. A substantial percentage of this category can be ascribed to hospitals' increased immunotherapy spending.

In 2019, North America held the greatest proportion of the immunotherapy drugs market. The rising prevalence of cancer and autoimmune diseases, the rising need for safer cancer therapies, the increasing number of FDA approvals, and the implementation of advantageous reimbursement policies are all factors contributing to this region's big proportion of the global market. The market in Asia Pacific is expected to grow.

F. Hoffmann-La Roche, Inc., Pfizer Inc. (US), Merck & Co. (US), Novartis International AG (UK), Johnson & Johnson (US), Sanofi (France), GlaxoSmithKline Plc (UK), Amgen Inc. (US), AbbVie Inc. (US), Boehringer Ingelheim AG (Germany), Sanofi (France), GlaxoSmithKline Plc (UK), Amgen Inc. (US), AbbVie Inc. (US) (Germany),

Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more